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Abstract 
Analysis of a diabetes clinical information system in Tayside, Scotland, shows that a significant 
proportion of insulin-treated patients with diabetes are not self-monitoring blood glucose 
according to current clinical guidance and recommendations, with some not self-monitoring 
their blood glucose at all.  Although there has been an increase in the numbers of reagent 
strips dispensed over the past decade, this increase is mainly accounted for by increased 
testing frequency among people with diabetes already testing.  
Introduction 
Self-monitoring of blood glucose (SMBG) is fundamental to diabetes self-management for people 
with type 1 diabetes and those with type 2 diabetes treated with insulin (1,2) with an important role 
to play in the prevention of hypoglycaemia and in the reduction of longer-term complications. 
Current guidance recommends routine SMBG in type 1 diabetes; at least four times per day and 
possibly even up to ten times daily, with frequency and timing individualized to the patient (1–3).  
Guidance for type 2 diabetes suggests that routine testing should be undertaken by people treated 
with insulin (1,4–6) and anyone at particular risk of hypoglycaemia. 
Studies have shown a general increase in self-monitoring over the past two decades in the UK 
and elsewhere (7,8).  Frequency of testing has increased alongside increases in the numbers 
of those testing.  A study in Scotland identified an increase in the proportion of all people with 
type 2 diabetes carrying out any SMBG from 15.5% in 1993 to 29.8% in 2009 (7). However, it 
is perhaps more important to assess the level of testing in patient groups for whom regular 
testing is specifically recommended. We therefore used a record-linkage diabetes clinical 
information system in Tayside, Scotland, to investigate patterns and levels of self-monitoring 
among people with type 1 diabetes and those with type 2 diabetes who are treated with 
insulin.  
 
 
 
Methods  
 
The Health Informatics Centre, University of Dundee (9,10) uses the record-linkage of health 
care data to facilitate epidemiological and health services research in Scotland. Record-
linkage is enabled by the widespread use of a unique health care identifier (CHI number) that 
is allocated to people when they register with a General Practitioner (GP) in Scotland. SCI-DC 
(Scottish Care Information – Diabetes Collaboration) is a validated population-based diabetes 
information system, compiled by record-linking several independent data sources [6]. 
Detailed clinical information is available via SCI-DC for all people with diabetes. There are also 
computerised records of prescriptions dispensed, including those for self-monitoring 
equipment to residents of the region of Tayside, (current estimated population is 412,160). 
These are free of charge so almost everyone with diabetes is likely to obtain their reagent 
strips via this route.  
People in Tayside with either type 1 or type 2 diabetes, who were dispensed at least one 
prescription of insulin during that year were identified for the period 2004 to 2011. The total 
numbers of SMBG reagent strips dispensed to them were calculated from information on the 
prescription. A cross-sectional analysis of a 3 year period 1/1/2009 - 31/12/20011 was also 
undertaken. We investigated whether SMBG patterns were associated with age, sex and a 
postcode measure of material deprivation that classified people into quintiles of deprivation 
(according to information on income, employment, health and disability, education, skills, and 
training and access to services for small geographical areas) [6].  Proportions testing within 
sub-groups and the median number of strips dispensed in the 3-year period were also 
determined.    
 
  
 
 
 
 
 
 
 
 
 
Results 
The overall numbers of SMBG reagent strips dispensed has almost doubled over time, from 
833,500 strips dispensed to 1,225 people with type 1 diabetes in 2004, to 1,547,950 strips 
dispensed to 1,573 people in 2011.  Similarly, in type 2 diabetes, numbers of SMBG strips 
dispensed increased from 950,400 dispensed to 1,830 people treated with insulin in 2004 to 
1,416,200 dispensed to 2,473 people in 2011 (Table 1).  
 
The proportion of people with type 1 diabetes who received any strips increased from 72% in 
2004 to 80% in 2011, suggesting that there are still around one in five who are not testing at 
all. The approximate doubling in the number of strips dispensed over time can be attributed 
almost equally to increased numbers of people testing, and to increased frequency among 
those already testing (as shown by an increase in the median number of strips dispensed). In 
contrast, in type 2 diabetes, the proportion who test has remained relatively stable over the 
study period; 88% in 2004 and 91% in 2011. The large increase in the overall number of strips 
dispensed is therefore accounted for by increases in testing frequency among those who 
already test, rather than being an indication of wider engagement with SMBG. Despite this, 
many people are still not receiving enough strips to test more than once or twice daily, 
although testing frequency is higher in type 1 diabetes.   
 
Table 2 shows that between 2009 and 2011, women were more likely to test, and people 
with type 1 diabetes were testing more frequently. There was an effect of deprivation on 
frequency of testing, with people living in less deprived areas testing more frequently than 
those living in more deprived areas. In general, testing frequency increased with age but the 
proportion of older people (70+ years) doing any testing with type 2 diabetes was 
particularly low.  
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Despite a body of evidence identifying the importance of SMBG in maintaining glycaemic 
control and in turn decreasing the risk of diabetic related complications (6,10), around 10-
20% of people with type 1 and type 2 diabetes who are treated with insulin are not testing at 
all. This level of non-testing has remained stable over the last decade. Furthermore, testing is 
not carried out as frequently as recommended within both patient groups.  These low levels 
of testing are worrying given the importance of SMBG in the prevention of hypoglycaemia, 
and possible implications for behaviours such as driving. There is also evidence that SMBG 
may be associated with reductions in diabetes-related complications. These findings 
therefore have significant implications for health costs for individual people and health 
services. (10–12).  
 The effect of deprivation on frequency of testing has been noted by several authors, in 
particular in type 2 diabetes, and is a concern given its potential to widen inequalities in 
diabetes outcomes (7,13–16).  It is important that everyone who is treated with insulin and 
for whom SMBG may be beneficial has appropriate knowledge surrounding testing 
recommendations and the practice of self-monitoring (16)..   
The strengths of this study are its population-based approach and the use of a validated 
diabetes clinical information system, with records of dispensed prescriptions for reagent 
strips. However, we cannot be sure that people necessarily used the reagent strips that were 
dispensed to them; neither can we be sure that some did not receive strips from other 
sources. The study does identify a need for a deeper understanding of why people are not 
self-monitoring in line with current guidance.  There is a need to investigate further how 
people are testing and as well as influences on testing behaviours. 
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TABLES 
Table 1: Numbers of SMBG reagent strips dispensed by year and the number of patients with any 
strips dispensed     
 
Year Type 1 diabetes Type 2 diabetes 
 No. of  
patients 
No.  of 
strips 
dispensed 
No. (%) of 
patients with 
strips 
dispensed 
Median 
no. of 
strips 
dispensed 
per day1  
No. of  
patients 
No.  of 
strips 
dispensed 
No. (%) of 
patients 
with strips 
dispensed 
Median 
no. of 
strips 
dispense
d per 
day1  
 
2004 
 
1698 
 
833500 
1225  72%  
1.4 
 
2073 
 
950400 
1830  88%  
1.1 
 
2005 
 
1712 
 
882250 
1464  85%  
1.2 
 
2125 
 
1096300 
1934  91%  
1.2 
 
2006 
 
1802 
 
1100200 
1376  76%  
1.6 
 
2273 
 
1201350 
2065  91% 
 
 
1.2 
 
2007 
 
1845 
 
536000 
1207  65%  
0.8 
 
2228 
 
1018100 
1952  88%  
1.1 
 
2008 
 
1882 
 
648450 
1179  64% 1.0  
2246 
 
1006555 
1959  87% 1.1 
 
2009 
 
1951 
 
810900 
1337  68% 0.5 
 
 
2466 
 
1236950 
2176  88%  
1.2 
 
2010 
 
1946 
 
1432100 
1554  80% 1.9  
2597 
 
1352100 
2337  90%  
1.2 
 
2011 
 
1969 
 
1574950 
1573  80%  
2.2 
 
2718 
 
1416200 
2473  91%  
1.4 
1Among patients with any strips dispensed 
 
 
 
 
 
 
Table 2: Numbers of SMBG reagent strips dispensed and numbers of patients receiving strips, 
stratified by gender, age and deprivation 
  
 
Attribute   Type 1 diabetes Type 2 diabetes 
 N No.  
of 
patie
% of 
patients 
Median  
no. of 
strips 
N No. of 
patients 
% of 
patients 
Median  
nts 
with 
strips 
dispe
nsed 
with strips 
dispensed 
dispensed 
per day1 
with strips 
dispensed 
with strips 
dispensed 
no. of strips 
dispensed 
per day 1 
Gender 
Female 818 738   90% 1.8 941 872  93% 1.0 
Male 982 845   86% 1.4 1053 950  90% 1.1 
Age 
1  13-24 408 362   89% 1.4 4 4     100% 0.3 
2  25-40 539 451    84% 1.1 70 56   80% 0.5 
3  41-55 545 483    89% 1.6 377 338   90% 0.7 
4  56-70 233 218    94% 2.1 848 789  93% 1.0 
5  70+ 75 69  92% 2.4 694 534   77% 1.4 
Deprivation quintile  
1(most 
deprived) 
324 287    89% 1.2 448 412  92% 0.9 
2 364 312    86% 1.3 426 392    92% 0.9 
3 342 308   90% 1.7 394 357    91% 1.2 
4 389 334  86% 1.8 373 341   91% 1.0 
5 (least 
deprived)  
312 284   91% 1.9 307 292 92% 1.2 
1Among patients with any strips dispensed 
 
 
 
 
